Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedIPD data-sharing details and access criteria were added, along with references to study documents and publications, expanding the available resources and data-access options for the Lebrikizumab trial.SummaryDifference100%

- Check14 days agoChange DetectedThe page now shows Revision: v3.6.5 instead of Revision: v3.6.4, indicating a small platform update to the page's underlying framework. There is no indication of changes to the trial content or study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision tag updated to v3.6.3, indicating a newer site build. This update does not modify the study details or other user-facing content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe revision label was updated from v3.6.0 to v3.6.2, representing a minor software release for the page rather than a change to the study details.SummaryDifference0.0%

- Check71 days agoChange DetectedThe study page now shows 'No longer looking for participants,' indicating enrollment has closed and no new participants are being recruited. This reflects a recruitment status update to ensure the study record accurately represents current status.SummaryDifference0.2%

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.